Active, not recruitingNo phase
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
Key facts
- Where
- Akron, Albuquerque, Austin, Bay Shore, Bethlehem, Boston, Chandler, Chula Vista, Cincinati, Colorado Springs, Columbia, Denver, Des Moines, Evansville, Fort Worth, Hartford, Hollywood, Huntington, Jacksonville, Kansas City, Lakewood, Lansing, Little Rock, Louisville, Manhasset, Milwaukee, Mount Kisco, Nashville, New Haven, New Hyde Park, New York, Ocean City, Omaha, Panama City, Poughkeepsie, Raleigh, Rochester, Safety Harbor, Salisbury, Sarasota, Silver Spring, St Louis, Staten Island, Van Nuys, Ventura, and Ypsilanti, United StatesSee the 51 sites
Where in United States
- Summa Center for Clinical Trials-Northeast Ohio Cardiovascular SpecialistsAkron, United StatesNo longer taking part
- Presbyterian Heart GroupAlbuquerque, United StatesNo longer taking part
- Texas Cardiac Arrhythmia Research FoundationAustin, United StatesNo longer taking part
- South Shore University HospitalBay Shore, United StatesNo longer taking part
- St. Luke's University Health NetworkBethlehem, United StatesNo longer taking part
- Brigham and Women's Hospital (Boston MA)Boston, United StatesNo longer taking part
- Southwest EPChandler, United StatesNo longer taking part
- Chula Vista Cardiac CenterChula Vista, United StatesNo longer taking part
- The Christ Hospital Health NetworkCincinati, United StatesNo longer taking part
- Colorado Springs CardiologyColorado Springs, United StatesNo longer taking part
- Missouri Cardiovascular SpecialistsColumbia, United StatesNo longer taking part
- University Hospital (Columbia MO)Columbia, United StatesNo longer taking part
- Denver HeartDenver, United StatesNo longer taking part
- Iowa Heart Center (West Des Moines IA)Des Moines, United StatesNo longer taking part
- Deaconess Specialty PhysiciansEvansville, United StatesNo longer taking part
- Consultants in Cardiology (Fort Worth TX)Fort Worth, United StatesNo longer taking part
- Heart Center of North TexasFort Worth, United StatesNo longer taking part
- Hartford HospitalHartford, United StatesNo longer taking part
- Heart Rhythm SolutionsHollywood, United StatesNo longer taking part
- Huntington HospitalHuntington, United StatesNo longer taking part
- Baptist HealthJacksonville, United StatesNo longer taking part
- Saint Lukes Health SystemKansas City, United StatesNo longer taking part
- The University of Kansas Medical CenterKansas City, United StatesNo longer taking part
- Colorado Heart and Vascular PCLakewood, United StatesNo longer taking part
- Sparrow Clinical Research InstituteLansing, United StatesNo longer taking part
- Saint Vincent Heart Clinic ArkansasLittle Rock, United StatesNo longer taking part
- Norton Heart and Vascular InstituteLouisville, United StatesNo longer taking part
- North Shore University HospitalManhasset, United StatesNo longer taking part
- Aurora Cardiovascular ServicesMilwaukee, United StatesNo longer taking part
- Northern Westchester HospitalMount Kisco, United StatesNo longer taking part
- Saint Thomas Research InstituteNashville, United StatesNo longer taking part
- Yale New Haven HospitalNew Haven, United StatesNo longer taking part
- Long Island Jewish Medical CenterNew Hyde Park, United StatesNo longer taking part
- Lenox Hill HospitalNew York, United StatesNo longer taking part
- New York-Presbyterian Hospital/Weill Cornell Medical CenterNew York, United StatesNo longer taking part
- NewYork-Presbyterian / Columbia University Irving Medical CenterNew York, United StatesNo longer taking part
- Monmouth Cardiology AssociatesOcean City, United StatesNo longer taking part
- Nebraska MedicineOmaha, United StatesNo longer taking part
- Cardiovascular Institute of Northwest FloridaPanama City, United StatesNo longer taking part
- Hudson Valley Heart CenterPoughkeepsie, United StatesNo longer taking part
- WakeMed Health & HospitalsRaleigh, United StatesNo longer taking part
- Mayo Clinic, Rochester, MNRochester, United StatesNo longer taking part
- Heart & Vascular Institute of FloridaSafety Harbor, United StatesNo longer taking part
- Tidal Health Peninsula RegionalSalisbury, United StatesNo longer taking part
- Heart Rhythm Consultants P.A. (Sarasota Memorial Research)Sarasota, United StatesNo longer taking part
- Associates in Cardiology PASilver Spring, United StatesNo longer taking part
- Washington University School of MedicineSt Louis, United StatesNo longer taking part
- Staten Island University HospitalStaten Island, United StatesNo longer taking part
- Cardiovascular Consultants Medical Group (Van Nuys CA)Van Nuys, United StatesNo longer taking part
- Cardiology Associates Medical GroupVentura, United StatesNo longer taking part
- Michigan HeartYpsilanti, United StatesNo longer taking part
Trial details
- Who runs it
- Medtronic
- Trial code
- NCT04496518
- Record updated
- 20 October 2025
- Original description
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices.Read full original descriptionShow less
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices.
The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Inclusion: Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements; Patient is intended to receive or is implanted with an iATP-capable device with iATP on in any zone with ventricular ATP therapies programmed; Patient is enrolled in the CareLink network for remote device monitoring.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results; Patient who is, or is expected to be inaccessible for follow-up; Patient with exclusion criteria required by local law.